MNKD

MannKind Corporation

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$4.16

Price (1 Year)

$5.94 $2.28

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %23.4 / %30
Non-compliant assets / Total market cap %6.1 / %30
Non-compliant revenue / Total income %1.2 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. It develops and commercializes treatments that address various unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.

Website

Analysis (Turkish): MNKD Hissesi Caiz mi, Helal mi? MannKind Corporation Katılım Analizi